ScopusElsevier Scopus
Status
Active
Coverage
2004–2026
Source type
Journal
Open access
No
CiteScore
7.7
Best quartile
Q1 · 91st pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Complementary and Alternative Medicine | 10 / 115 | 91st | Q1 |
| Drug Discovery | 39 / 161 | 76th | Q1 |
Chinese Journal of Natural Medicines
ISSN 1875-5364 · 2095-6975
Publisher: China Pharmaceutical University
Scopus · Q1WoS · SCIEONOS
Is Chinese Journal of Natural Medicines indexed in Scopus? Yes — actively indexed in Scopus, coverage 2004–2026, best quartile Q1, CiteScore 7.7.
Is Chinese Journal of Natural Medicines in Web of Science? Yes — indexed in the Science Citation Index Expanded.
Is Chinese Journal of Natural Medicines open access? No — it is not registered as an open-access journal in DOAJ or Scopus.
7.7
CiteScore 2025
Scopus
Q1
Best quartile
91st percentile
2
Indexed in
major indexes
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Checking DOAJ…
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Official sources & links
Related journals
Explore this journal in the interactive dashboard →
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.